Tumor vasculature via hepatic artery flow dynamics

Tumor vasculature via hepatic artery flow dynamics" does not refer to a specific molecule, receptor, or canonical therapeutic target. Instead, it describes the **physiological process** by which blood flow through the hepatic artery supplies nutrients and oxygen to liver tumors. Research shows that both the hepatic artery and portal vein can nourish small intrahepatic tumors[2][3]. The dynamics of this blood supply are important in understanding tumor growth and in developing interventional therapies such as transarterial chemoembolization (TACE), but "tumor vasculature via hepatic artery flow dynamics" is not itself a molecular entity or druggable target[1][2][3]. Therefore, it cannot be classified under standard molecular target categories such as receptor, enzyme, transporter, etc., nor does it have an official abbreviation or aliases.